Social Forum >> Forum Thread
Last Price Today's Change   Day's Range   Trading Volume
0.44   -0.01 (2.22%)  0.44 - 0.45  278,000
1,666 comment(s). Last comment by PennyStock123 at Sep 13, 2021 8:57 AM
 7 people like this.
 Post Reply   Back  
Page < 25 26 27 28 29 30 31 32 33 34

1402 posts

Posted by Peace99 > Jul 23, 2021 11:18 AM | Report Abuse

Not bad!

3921 posts

Posted by rogers123 > Jul 27, 2021 11:02 PM | Report Abuse

Technology group OMESTI Berhad has launched the OMESTI Healthcare Vaccin8
Programme to provide vaccination services to companies for their employees as
part of the nationwide drive to combat COVID-19.
The Programme, offered by the OMESTI Healthcare Division, will provide safe and convenient
access to vaccinations for Malaysian companies to protect as many of their employees as
quickly as possible and so help businesses resume normal operations. Authorised by the JKJAV
(Jawatankuasa Khas Jaminan Akses Bekalan Vaksin COVID-19) and the Ministry of Health
Malaysia, the Vaccin8 Programme enables OMESTI to lend its support to the National COVID19 Immunisation Programme (NCIP).
Gerard Monteiro, Executive Director of OMESTI Berhad, says, “We are honoured to be able to
do whatever we can to assist in the NCIP and help combat the COVID-19 Pandemic. We firmly
believe that mass-vaccination of the workforce, especially in Malaysia’s critically important
industries, is the only way to protect lives and ensure that livelihoods can be sustained.”
Mr Monteiro adds, “In setting up the OMESTI Healthcare Vaccin8 Programme, we have been
able to leverage our substantial technology heritage in the successful delivery of complex
multi-stakeholder systems to help roll out this vital initiative for the country. The sooner the
majority of the population is protected, the sooner the economy can regain its footing and we
can begin to open up to international business once more.”
OMESTI Berhad has invested in Bemed Tempua Sdn Bhd, a pharmaceutical company which
has been granted approval to acquire an initial allocation of one (1) million doses of the
Sinovac vaccine from Pharmaniaga LifeScience Sdn Bhd.
OMESTI has also engaged the services of licensed healthcare provider Mudah Healthcare Sdn
Bhd (Mudah Healthcare) as its delivery partner for the Vaccin8 Programme. “Our medical
teams will be mobilised to carry out vaccinations on site at company premises, even in remote
locations, offering safety, convenience and flexibility while minimising disruption to business
operations. Appointments can also be arranged at clinics and medical centres convenient to
company premises,” adds Mr Monteiro.
Page 2 of 2
Once completed, all details of the COVID-19 vaccinations provided under the OMESTI Vaccin8
Programme will be reflected in MySejahtera to ensure a reliable and complete ‘single source
of truth’ on the status of vaccinated individuals in Malaysia.
The Vaccin8 Programme has already attracted significant interest from Malaysian companies
and conglomerates in the financial services, plantation, manufacturing and hospitality sectors.
COVID-19 testing services will also be added to the Group’s portfolio in the near future,
enabling companies to conduct mass-testing of employees. This will help contain the risk of
infection, while ensuring compliance with the mandatory requirements for testing that apply
to many industry sectors under the Government SOPs.
Companies that are interested in obtaining vaccinations for their employees simply need to
email vaccin8@omesti.com.
OMESTI Berhad is a Malaysian-based public listed grouping of companies that specialises in helping
clients achieve digital transformation of their operations on both an enterprise-wide and modular basis.
Its portfolio includes proprietary solutions for digital court technology, corporate registry systems and
core banking as well as e-payments, data services, digital HR, cloud applications and IoT solutions.
It is an authorised technology/distribution partner for some of the world’s leading principals including
Huawei, IBM, Lenovo, HPE, Oracle, AWS, Alibaba and Google. It works with large enterprises across
multiple industry sectors including financial institutions, telecommunications, utility and energy firms,
the judiciary, regulatory bodies, education and various government departments. The Group also
provides solutions on an as-a-service basis for e-payments, royalty management, corporate secretarial,
human capital management, and more. www.omesti.com

3921 posts

Posted by rogers123 > Jul 27, 2021 11:03 PM | Report Abuse

Omesti got the vaccine

38 posts

Posted by varane > Jul 28, 2021 9:21 AM | Report Abuse

What's the target price after this?

1402 posts

Posted by Peace99 > Aug 6, 2021 5:39 PM | Report Abuse

They got 1 million doses of Sinovac....what other vaccines they will be getting?

2504 posts

Posted by Yu_and_Mee > Aug 6, 2021 8:29 PM | Report Abuse

forget about this goreng stock, same as microln and others "stocks" unless you know when to exit.
many loss money because jump in and don't know when to jump out

1402 posts

Posted by Peace99 > Aug 7, 2021 5:24 PM | Report Abuse

But is Omesti not doing honest profitable business?

213 posts

Posted by Drachen > Aug 20, 2021 11:46 AM |

Post removed. Why?

25 posts

Posted by kermit21 > Aug 24, 2021 11:24 AM | Report Abuse

@Drachen. link pls.

213 posts

Posted by Drachen > Aug 24, 2021 11:28 AM |

Post removed. Why?

213 posts

Posted by Drachen > Aug 24, 2021 12:00 PM | Report Abuse

From Rakuten Trade's Research Hive:
Omesti Bhd (Fundamental BUY with TP 0.71)

Omesti Bhd (Omesti) is primarily involved in providing network connectivity and bandwidth services, and project management services in relation to telecommunications via its 51.8% subsidiary Microlink Bhd.

On 27 July 2021, the company acquired a 70% stake in Bemed Tempua Sdn. Bhd. (Bemed Tempua) for RM700,000 and is now a Covid-19 vaccine provider for the private sector.

Omesti jumped into the Covid-19 vaccine bandwagon and launched the Omesti Healthcare Vaccin8 Programme (“Healthcare Programme”) providing vaccination services to companies for their employees as part of the nationwide drive to achieve herd immunity status.

Authorised by the Jawatankuasa Khas Jaminan Akses Bekalan Vaksin COVID-19 (JKJAV) and the Ministry of Health Malaysia (MOH), the 1m doses of Sinovac vaccines acquired from Pharmaniaga enables Omesti to execute its Healthcare Programme. In addition, Omesti is also providing Oral Fluid Antigen Test Kit (approved by the MOH) to existing clients and via online marketing. Demand for its vaccines and test kits remains resilient as the company has already secured substantial orders from companies across different sectors.

Balance sheet is healthy with net cash position of RM27.7m as at FY21.

This new source of income will greatly enhance Omesti’s earnings for FY22 and beyond. BUY with a target price of RM0.71 based on sum of parts valuation, implying a forward PER of 16.5x for FY22. Our BUY recommendation is premised on: (i) strong sales achieved since the launch of Healthcare Programme; (ii) orders secured from the private sectors providing recurring earnings; and (iii) healthy profit margins going forward.

Sc Lee
65 posts

Posted by Sc Lee > Aug 30, 2021 9:24 AM | Report Abuse

very bad company,lossing all the years!

349 posts

Posted by PennyStock123 > Sep 8, 2021 4:08 PM | Report Abuse

.......1Q net profit 0.301 million (increased 6.74%)......27 Aug 2021 5:08PM

349 posts

Posted by PennyStock123 > Sep 8, 2021 4:14 PM | Report Abuse

.......Omesti Director....Mr. Monteiro Gerard Clair started to buy....

25 posts

Posted by kermit21 > Sep 10, 2021 11:08 PM | Report Abuse

@ PennyStock123 how you found out?

349 posts

Posted by PennyStock123 > Sep 13, 2021 8:57 AM | Report Abuse

......annoucement available on Bursa website.....https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3182926

 Post Reply   Back  
Page < 25 26 27 28 29 30 31 32 33 34
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Perform Technical & Fundamental Analysis on Stocks
MQ Affiliate
Earn rewards by referring your friends

452  498  551  764 

Top 10 Active Counters
 KNM 0.265+0.005 
 FINTEC 0.0250.00 
 DNEX 0.80+0.04 
 EMICO 0.665+0.14 
 AT 0.06-0.005 
 PASUKGB-WA 0.0150.00 
 KTG 0.140.00 
 PASUKGB 0.1150.00 
 YB-LA 0.0750.00 
 TFP 0.225+0.005